Persistently high prevalence of primary resistance and multidrug resistance of tuberculosis in Heilongjiang Province, China. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Li, Di; Wang, Jing-Li; Ji, Bin-Ying; Cui, Jia-Yi; Pan, Xin-Ling; Fan, Chang-Long; Shao, Chang-Xia; Zhao, Li-Na; Ma, Yuan-Ping; Zhang, Liu-Zhuo; Zhang, Chun-Lei; Dong, Cai-Bo; Hattori, Toshio; Ling, Hong
• Is Part Of: BMC infectious diseases. Volume 16:Issue 1(2016)
• Page Start: 1
• Page End: 8
• Publication Date: 2016-12
• Subjects: Mycobacterium tuberculosis -- Primary resistance -- Multi-drug resistance -- Risk factors; Communicable diseases -- Periodicals; Sexually Transmitted Diseases -- Periodicals; 616.905
• DOI: 10.1186/s12879-016-1848-9
• Languages: English
• ISSNs: 1471-2334

Abstract

Abstract Background The spread of multidrug-resistant tuberculosis (MDR-TB)Mycobacterium tuberculosis (M. tuberculosis ) strains has been a big challenge to the TB control and prevention in China. Knowledge about patterns of drug resistance in TB high-burden areas of China is crucial to develop appropriate control strategies. We conducted a comprehensive investigation of the resistance pattern ofM. tuberculosis in Heilongjiang Province. Methods 1427 M. tuberculosis clinical strains were isolated from pulmonary TB patients hospitalized between 2007 and 2012. The susceptibility of the isolates to the first-line anti-TB drugs and the resistance of MDRM. tuberculosis to fluoroquinolones were examined. We also performed a statistical analysis to identify the correlated risk factors for high burden of MDR-TB. Results The global resistance rates of 2007–2012 to the first-line drugs and MDR were 57.0 and 22.8 %, respectively. Notably, the primary MDR-TB and pan-resistance rates were as high as 13.6 and 5.0 %, respectively. Of MDRM. tuberculosis isolates (2009), approximately 13 % were not susceptible to any of the fluoroquinolones tested. Being age of 35 to 54, high re-treatment proportion, the presence of cavity lesion, and high proportion of shorter hospitalization are correlated with the development of MDR-TB. Conclusions The high prevalence of drug resistant, MDR-TB, and fluoroquinolone-resistant MDR-TB is a big concern for TB control. More importantly, in order to control the development of MDR-TB effectively, we need to pay more attention to the primary resistance. Targeting reducing the prevalence of the risk factors may lead to better TB control in China.